Alzheimer; News from the web:
The recent FDA approval of a new medicine for Alzheimer’s has still some questions about who is eligible to get it, the costs and more. Read the article in our link for today for some insights.
Read all about it HERE
Understanding the differences between Alzheimer’s and dementia
Alzheimer; News from the web:
For years, the terms “Alzheimer’s” and “dementia” have been used interchangeably. But the difference between them is important, say experts at the Oklahoma Medical Research Foundation, with no better time to learn than June: Alzheimer’s and Brain Awareness Month.
Read all about it HERE
The Cure and the Cost
Alzheimer; News from the web:
A newly approved drug to treat Alzheimer’s disease is expected to become a multibillion-dollar expense for Medicare. By one projection, spending on the drug for Medicare’s patients could end up being higher than the budgets for the Environmental Protection Agency or NASA.
Read all about it HERE
Plant can help Alzheimer patients?
Alzheimer; News from the web:
A plant commonly found in Indian gardens could hold molecules to treat Alzheimer’s, a brain disease that severely affects behavior and memory, said researchers in Bengaluru.
Read all about it HERE
The cost for the cure
Alzheimer; News from the web:
With the new approved drug for Alzheimer’s there is now the issue of what it will cost and how you’ll be able to afford it.
Biogen said the drug would cost approximately $56,000 for a typical year’s worth of treatment, and it said the price would not be raised for four years.
Medicare is widely expected to cover the treatment. Insurers that offer private or commercial coverage also will pay for care that doctors deem medically necessary.
That may not mean every case, though. If the treatment is proposed for a patient with advanced Alzheimer’s, and research shows the drug isn’t effective in that population, then the insurer may not pay for it.
Read all about it HERE
YES new drug approved for Alzheimer’s
Alzheimer; News from the web:
Truly great news today, the new drug Aducanumab has been approved by the FDA for use in early Alzheimer’s cases.
The drug was developed for patients with mild cognitive impairment, not severe dementia, and intended to slow progression of Alzheimer’s disease — not just ease symptoms.
Read all about it HERE